Jess Pacheco-Torres1, 2, Pilar Lopez-Larrubia1, Elena Nieto3, Ramn Alajarn3, Julio lvarez-Builla3, Paloma Ballesteros2, Sebastin Cerdn1
1Instituto de Investigaciones Biomdicas - CSIC, Madrid, Spain; 2Universidad Nacional de Educacin a Distancia (UNED), Madrid, Spain; 3Universidad de Alcal, Alcal de Henares, Madrid, Spain
Measurement of tumor oxygenation has gained importance in the last decades due to the known relationship between tumor hypoxia and tumor aggressiveness, poor outcome and resistance to therapies. Several techniques have been developed for this end (oxygen electrodes, EPR, PET) but none of them has gained widespread acceptance. 2-Nitroimidazole derivatives (EF5, Pimonidzole, 18F-MISO...) have been extensively used as molecular markers of hypoxia in combination with different techniques as immunohistochemistry, PET or 19F-MRI. Here we evaluate, for the first time to our knowledge, the use of these hypoxia markers in combination with 1H-MRSI to generate oxygenation maps in vivo.